Incannex Healthcare (NASDAQ: IXHL) approves new $20M stock buyback plan

Rhea-AI Filing Summary

Incannex Healthcare Inc. reported that its board has authorized a $20 million share repurchase program. This means the company now has approval to buy back up to that amount of its own common stock, which can reduce the number of shares held by the public over time if the program is used. The update was shared as an other event, with additional details provided in a related press release referenced in the filing.

Insights

Equity Capital Markets Analyst

Incannex authorizes a $20M share buyback, signaling flexibility in capital management.

Incannex Healthcare Inc. has authorized a share repurchase program of up to $20 million of its common stock. Such programs give management discretion to repurchase shares in the market or through other methods, which can reduce share count and support per-share metrics when executed.

The filing describes this as an authorization, so actual impact will depend on how much and how quickly the company chooses to repurchase. The decision adds another tool to manage its equity base alongside any operating or strategic priorities it may have, with further mechanics outlined in the referenced August 22, 2025 press release.

false 0001873875 0001873875 2025-08-22 2025-08-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 22, 2025

Incannex Healthcare Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-41106		93-2403210
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Suite 105, 8 Century Circuit Norwest, NSW 2153 Australia		Not applicable
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, including Area Code: +61 409 840 786

(Former Name or Former Address, if Changed Since Last Report): Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of exchange on which registered
Common Stock, $0.0001 par value per share		IXHL		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On August 22, 2025, Incannex Healthcare Inc. Authorizes $20 Million Share Repurchase Program. Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release of Incannex Healthcare Inc., dated August 22, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Incannex Healthcare Inc.
Date: August 22, 2025		/s/ Joel Latham
	Name:	Joel Latham
	Title:	Chief Executive Officer and President

2

FAQ

What did Incannex Healthcare Inc. (IXHL) announce in this 8-K filing?

Incannex Healthcare Inc. disclosed that it has authorized a $20 million share repurchase program for its common stock under Item 8.01 (Other Events).

How large is Incannex Healthcare Inc.'s new share repurchase authorization?

The company has authorized a share repurchase program of up to $20 million of its common stock.

Does the Incannex (IXHL) filing describe how the $20 million buyback will be executed?

The filing states that a $20 million share repurchase program has been authorized and refers investors to a press release (Exhibit 99.1) for further information.

Where can investors find more details on Incannex Healthcare Inc.'s buyback program?

Additional details are provided in the press release dated August 22, 2025, attached as Exhibit 99.1 and incorporated by reference into the filing.

Is the $20 million share repurchase program for Incannex already in effect?

The company has authorized the $20 million program, meaning it now has approval to repurchase shares, subject to any terms described in the referenced press release.